Understand The Five Development Goals Of The 14th Pharmaceutical Industry
2022-03-25
Author: China Medical News
Views: 0
On December 20, at the "special forum on hot policies of the pharmaceutical industry" of the 13th China Pharmaceutical Strategy Conference co sponsored by the China Pharmaceutical Industry Information Center and the Central Youth Working Committee of the agricultural labor party, relevant persons from the consumer goods industry department of the Ministry of industry and information technology introduced the relevant situation of the 14th five year plan of the pharmaceutical industry. It is reported that during the "14th five year plan" period, China's pharmaceutical industry should achieve seven goals, such as initially forming an innovation driven development model, solving a number of neck problems as soon as possible, and some pharmaceutical enterprises entering the forefront of global pharmaceutical enterprises.
First, an innovation driven development model has been initially formed. The average R & D investment intensity of Listed Companies in the pharmaceutical industry has increased significantly. The number of newly listed innovative drugs and approved innovative drugs in European and American developed countries has increased, relying more on new products and new technologies to drive industrial growth. The key task is to lay out the original innovation, speed up technology integration, improve the innovation system, create a support platform, cultivate innovative enterprises, etc.
Second, the supply guarantee capacity has been further improved, the national supply guarantee capacity of essential drugs has been strengthened, the shortage of clinical drugs has been systematically improved, the number of varieties of drugs for the treatment of rare diseases has increased significantly, the national medical reserve system has been further improved, and the emergency R & D and emergency production capacity to deal with major disasters, epidemic situations or their emergencies have been significantly enhanced. The key tasks are to improve the emergency response mechanism, optimize the emergency review and approval process, strengthen the emergency R & D and production capacity, strengthen the reserve of drugs and medical protection materials, and increase the medical facilities for epidemic prevention and treatment.
Third, the level of industrial chain supply chain modernization should be improved. We should further promote it in an overall way, supplement the short board and forge the long board, solve a number of neck problems as soon as possible, intensively cultivate in the fields of industrial advantages, and form an industrial chain supply chain with stronger innovation, higher added value, safer and more reliable. The key task is to do a good job in the strategic design and accurate implementation of supply chain; Maintain the competitive advantage of API products and promote key enterprises to achieve breakthroughs in drug design, production process, high-end excipients, pharmaceutical equipment and other links; Promote the orderly transfer of industries in China and optimize the layout of regional industrial chain.
Fourth, the industrial structure was significantly optimized, the integration of production capacity was further accelerated, the proportion of the main business income of the top 100 enterprises increased significantly, and some pharmaceutical enterprises ranked among the top pharmaceutical enterprises in the world. The key tasks are to raise the threshold of industry access, promote industry restructuring and integration, guide the development of industrial agglomeration, and support the development of producer services.
Fifth, improve the green development level of API industry, interpret and solve the prominent problems restricting the development of the industry such as hazardous waste treatment and VOCs emission, improve the green manufacturing level of API, and further promote the development and application of cleaner production technology; The production of API will be concentrated to advantageous enterprises, forming a number of high-level API green development parks. The key tasks are to adjust the industrial structure, optimize the industrial layout, speed up technological innovation and application, and implement green production standards.
Sixth, the advanced manufacturing level has been continuously improved, the application of advanced manufacturing technology in enterprises has increased, the production efficiency and large-scale level of factories have been improved, and the continuous, digital, intelligent and integrated level of pharmaceutical process has been improved, so as to build a number of benchmark factories with world advanced level. The key task is to improve the informatization and intelligent manufacturing level of the whole industry, promote enterprises to focus on "quality and efficiency", implement digital transformation in R & D and design, production and manufacturing, logistics and warehousing, operation and management, improve quality control, improve production and operation efficiency and reduce production costs. Improve the level of safety management and promote enterprises to establish a scientific, systematic, active, advanced and comprehensive accident prevention system based on "intrinsic safety".
Seventh, the internationalization strategy was further implemented, and the average annual growth rate of pharmaceutical exports maintained medium and high growth. The export proportion of pharmaceutical preparations and medium and high-end medical equipment has increased, and the international market sales of innovative drugs have formed a scale. The key task is to strive to increase the number of generic drugs registered in European and American developed countries and improve the technical content and added value. Accelerate a number of overseas clinical research projects entering phase II and phase III, and achieve more breakthroughs in the international registration of domestic innovative drugs as soon as possible.
Recommended News
- Six Auxiliary Traction Techniques: Making Endoscopic Mucosal Dissection Simple
- Notice Of The Comprehensive Department Of The State Food And Drug Administration On The Implementation Of The Measures For The Administration Of Monitoring And Re Evaluation Of Adverse Events Of Medical Devices
- Special Review Procedures For Innovative Medical Devices Issued By The State Food And Drug Administration
- Annual Academic Conference On Digestive Endoscopy: A Feast Of Tunnel Technology
- Announcement Of The State Drug Administration On Amending The Requirements For Some Application Materials Such As The Continuous Registration Of Medical Devices